申请人:INNOV17 LLC
公开号:US20150252022A1
公开(公告)日:2015-09-10
Provided herein are compounds of the formula (I):
as well as pharmaceutically acceptable salts thereof, wherein the substituents are as those disclosed in the specification. These compounds, and the pharmaceutical compositions containing them, are useful for the treatment of Retinoic Acid Receptor-Related Orphan Receptor regulated diseases and disorders.
本文提供了化合物的结构式(I),以及其药用盐,其中取代基如规范中所披露。这些化合物及含有它们的药物组合物对于治疗与视黄酸受体相关孤儿受体调节的疾病和紊乱有用。